Literature DB >> 15529157

Biomanufacturing, from bust to boom...to bubble?

Karl A Thiel.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15529157     DOI: 10.1038/nbt1104-1365

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  Through the looking glass: the protein science of biosimilars.

Authors:  David Goldsmith; Martin Kuhlmann; Adrian Covic
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

2.  Essential design considerations for the resazurin reduction assay to noninvasively quantify cell expansion within perfused extracellular matrix scaffolds.

Authors:  Joseph S Uzarski; Michael D DiVito; Jason A Wertheim; William M Miller
Journal:  Biomaterials       Date:  2017-02-16       Impact factor: 12.479

3.  Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations.

Authors:  Huafang Lai; Qiang Chen
Journal:  Plant Cell Rep       Date:  2011-12-02       Impact factor: 4.570

4.  Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2.

Authors:  Donovan Guttieres; Anthony J Sinskey; Stacy L Springs
Journal:  Antib Ther       Date:  2021-03-20

5.  Use of endogenous signal sequences for transient production and efficient secretion by moss (Physcomitrella patens) cells.

Authors:  Andreas Schaaf; Stefanie Tintelnot; Armin Baur; Ralf Reski; Gilbert Gorr; Eva L Decker
Journal:  BMC Biotechnol       Date:  2005-11-07       Impact factor: 2.563

6.  Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care.

Authors:  Pablo Perez-Pinera; Ningren Han; Sara Cleto; Jicong Cao; Oliver Purcell; Kartik A Shah; Kevin Lee; Rajeev Ram; Timothy K Lu
Journal:  Nat Commun       Date:  2016-07-29       Impact factor: 14.919

7.  New platform for simple and rapid protein-based affinity reactions.

Authors:  Kei Kubota; Takuya Kubo; Tetsuya Tanigawa; Toyohiro Naito; Koji Otsuka
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

8.  Expression systems and species used for transgenic animal bioreactors.

Authors:  Yanli Wang; Sihai Zhao; Liang Bai; Jianglin Fan; Enqi Liu
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

9.  Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk.

Authors:  Jianguo Zhao; Weijie Xu; Jason W Ross; Eric M Walters; Stephen P Butler; Jeff J Whyte; Lindsey Kelso; Mostafa Fatemi; Nicholas C Vanderslice; Keith Giroux; Lee D Spate; Melissa S Samuel; Cliff N Murphy; Kevin D Wells; Nick C Masiello; Randall S Prather; William H Velander
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.